MECP2 and macrophage activation syndrome: Glycine level might be affected by Dextromethorphan treatment for these RDs, for example, through methylation-related mechanism in Rett syndrome (with a mutation in methyl-CpG-binding protein 2 [MECP2]) or through glycogen synthase kinase in Macrophage activation syndrome (Chen et al., 2018).